JP2009531457A5 - - Google Patents

Download PDF

Info

Publication number
JP2009531457A5
JP2009531457A5 JP2009503206A JP2009503206A JP2009531457A5 JP 2009531457 A5 JP2009531457 A5 JP 2009531457A5 JP 2009503206 A JP2009503206 A JP 2009503206A JP 2009503206 A JP2009503206 A JP 2009503206A JP 2009531457 A5 JP2009531457 A5 JP 2009531457A5
Authority
JP
Japan
Prior art keywords
agents
buffers
antioxidants
stabilizers
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009503206A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009531457A (ja
JP5197569B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/064974 external-priority patent/WO2007117982A2/en
Publication of JP2009531457A publication Critical patent/JP2009531457A/ja
Publication of JP2009531457A5 publication Critical patent/JP2009531457A5/ja
Application granted granted Critical
Publication of JP5197569B2 publication Critical patent/JP5197569B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009503206A 2006-03-29 2007-03-27 有機化合物 Expired - Fee Related JP5197569B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78710406P 2006-03-29 2006-03-29
US60/787,104 2006-03-29
PCT/US2007/064974 WO2007117982A2 (en) 2006-03-29 2007-03-27 Organic compounds

Publications (3)

Publication Number Publication Date
JP2009531457A JP2009531457A (ja) 2009-09-03
JP2009531457A5 true JP2009531457A5 (enExample) 2010-04-22
JP5197569B2 JP5197569B2 (ja) 2013-05-15

Family

ID=38477291

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009503206A Expired - Fee Related JP5197569B2 (ja) 2006-03-29 2007-03-27 有機化合物

Country Status (12)

Country Link
US (1) US8153674B2 (enExample)
EP (2) EP2301931B1 (enExample)
JP (1) JP5197569B2 (enExample)
KR (1) KR20080114769A (enExample)
CN (1) CN101410389A (enExample)
AU (1) AU2007234968A1 (enExample)
BR (1) BRPI0709678A2 (enExample)
CA (1) CA2644391A1 (enExample)
ES (1) ES2442347T3 (enExample)
MX (1) MX2008012402A (enExample)
RU (1) RU2008142600A (enExample)
WO (1) WO2007117982A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101389246B1 (ko) 2004-07-15 2014-04-24 브리스톨-마이어스스퀴브컴파니 아릴- 및 헤테로아릴-치환된 테트라히드로이소퀴놀린, 및 이것의 노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기 위한 용도
CN101605777A (zh) * 2006-12-18 2009-12-16 诺瓦提斯公司 作为醛固酮合酶抑制剂的咪唑类化合物
EP2121652A1 (en) * 2006-12-18 2009-11-25 Novartis AG 4-imidazolyl-1,2,3,4-tetrahydroquinoline derivatives and their use as aldosterone/11-beta-hydroxylase inhibitors
EP2095819A1 (en) * 2008-02-28 2009-09-02 Maastricht University N-benzyl imidazole derivatives and their use as aldosterone synthase inhibitors
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
CN102458123A (zh) 2009-05-12 2012-05-16 阿尔巴尼分子研究公司 芳基、杂芳基和杂环取代的四氢异喹啉及其用途
CN102595902B (zh) 2009-05-12 2015-04-29 阿尔巴尼分子研究公司 7-([1,2,4]三唑并[1,5-a]吡啶-6-基)-4-(3,4-二氯苯基)-1,2,3,4-四氢异喹啉及其用途
CN102638982B (zh) 2009-05-12 2015-07-08 百时美施贵宝公司 (S)-7-([1,2,4]三唑并[1,5-a]吡啶-6-基)-4-(3,4-二氯苯基)-1,2,3,4-四氢异喹啉的晶型及其用途
CN103958478B (zh) * 2011-11-30 2017-08-01 霍夫曼-拉罗奇有限公司 双环二氢异喹啉‑1‑酮衍生物
RS60660B1 (sr) * 2011-11-30 2020-09-30 Hoffmann La Roche Novi biciklični derivati dihidroizohinolin-1-ona
EP2639212B1 (en) 2012-03-13 2016-03-09 The Provost, Fellows, Foundation Scholars, & the other members of Board, of the College of the Holy & Undiv. Trinity of Queen Elizabeth near Dublin Enantioselective organic anhydride reactions
DK3172212T3 (en) 2014-07-24 2018-08-27 Boehringer Ingelheim Int Aldosterone synthase inhibitors.
US10131642B1 (en) * 2015-01-30 2018-11-20 Boehringer Ingelheim International Gmbh Aldosterone synthase inhibitors
AU2018230521B2 (en) 2017-03-10 2022-02-03 Embera Neurotherapeutics, Inc. Pharmaceutical compositions and uses thereof
CN109232607A (zh) * 2018-09-20 2019-01-18 沈阳药科大学 劳拉替尼的合成方法
US11958818B2 (en) 2019-05-01 2024-04-16 Boehringer Ingelheim International Gmbh (R)-(2-methyloxiran-2-yl)methyl 4-bromobenzenesulfonate
TW202339719A (zh) 2021-12-14 2023-10-16 德商百靈佳殷格翰國際股份有限公司 用於治療慢性腎臟病之醛固酮合成酶抑制劑
CN120187713A (zh) * 2022-11-23 2025-06-20 上海翰森生物医药科技有限公司 吡啶多环类化合物抑制剂、及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0305332A3 (de) * 1987-08-26 1990-04-04 Ciba-Geigy Ag Imidazol-Derivate
DE102004035322A1 (de) 2004-07-21 2006-02-16 Universität des Saarlandes Selektive Hemmstoffe humaner Corticoidsynthasen

Similar Documents

Publication Publication Date Title
JP2009531457A5 (enExample)
WO2013066835A3 (en) Compounds and methods
WO2013066839A3 (en) Compounds and methods
AR088195A1 (es) Composiciones farmaceuticas de n-metil-2-[3-(e)-2-piridin-2-il-vinil)-1h-indazol-6-ilsulfanil]-benzamida
NZ602557A (en) Solid form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
WO2012088266A3 (en) Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
EA200870216A1 (ru) Амидо соединения и их применение в качестве лекарственных средств
EA201101192A1 (ru) Фармацевтическая композиция, включающая производные глюкопиранозилдифенилметана, фармацевтическая дозированная форма, содержащая указанные производные, способ их получения и применения для улучшения гликемического контроля у пациентов
EA201170703A1 (ru) Производные адамантилбензамида
MA32774B1 (fr) Antagonistes de récepteur de mélanocortine
MX2010007677A (es) Derivados de hidroximoil-tetrazol como fungicidas.
JO2973B1 (en) Fumarate salt for (alpha-beta-R) -6-bromo-alpha-[2- (methylamino) ethyl-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinoline ethanol
WO2008061724A3 (en) Compositions comprising carnosic acid 12-methylether
CN108026053A8 (zh) 作为mIDH1抑制剂的稠合的咪唑类化合物
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
ATE487720T1 (de) 5,6,7,8-tetrahydropteridin-derivate als hsp90- hemmer
MX2014013851A (es) Composiciones farmaceuticas topicas que comprenden terbinafina y urea.
WO2009120389A8 (en) Oral and injectable formulations of tetracycline compounds
PH12013500371A1 (en) Therapeutic agent for pain
PT1981862E (pt) Compostos relacionados com lantionina para o tratamento de doenças inflamatórias
WO2014064652A3 (en) Stable pharmaceutical composition of peginterferon alpha-2b
WO2010094452A3 (en) Composition comprising n2 - (1-oxohexadecyl) - lysyl - valyl - lysine for treating rosacea and its symptoms
WO2009097973A3 (de) Imidazopyridazine als par1-inhibitoren, ihre herstellung und verwendung als arzneimittel
EA201390844A1 (ru) Комплексный состав, содержащий гидрохлорид лерканидипина и валсартан, и способ его получения